Plasmapheresis Collection Systems
Scottish National Blood Transfusion ServicecontractFind a Tender ↗Ref ocds-h6vhtk-052ac632014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
02 Jun 2025
Description
There is a need for plasmapheresis devices to achieve a degree of self-sufficiency from volunteer plasma donations to manufacture Immunoglobulin (Ig) therapeutic product to meet clinical demand.
Scope
- Reference
- NSS08325 (NSS202112)
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33100000
- Contract locations
- Scotland
Submission & procedure
- Procedure
- Award procedure without prior publication of a call for competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Awarded suppliers· 1 supplier
Awarded —
Award value
—
Other contracts from Scottish National Blood Transfusion Service
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Fresenius Kabi· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Ustekinumab | contract | — | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| Transitional Drugs 7 | contract | — | 05 Jun 2026 |
| National Framework Agreement for the provision of an enteral feeding accessories delivery service | contract | — | 04 Jun 2026 |
| Home Parenteral Nutrition | contract | — | 18 May 2026 |
| D108 - Framework for the supply of Adult and Paediatric PN Products | contract | — | 05 May 2026 |
| Maintenance of Fresenius Kabi CATSmart systems | contract | — | 05 May 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - 1 June 2026 | contract | — | 10 Mar 2026 |
| Generic Drugs – Injections/Infusions 2 | contract | — | 03 Mar 2026 |